Sit Investment Associates Inc Neurocrine Biosciences Inc Transaction History

Sit Investment Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$75.79 - $100.07 $1.49 Million - $1.97 Million	-19,700 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $1.73 Million - $2.35 Million	19,700 New	19,700 $1.92 Million
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $953,012 - $1.26 Million	-13,750 Closed	0 $0
Q4 2018 Jan 14, 2019	BUY	$68.32 - $124.36 $259,615 - $472,568	3,800 Added 38.19%	13,750 $982,000
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $93,936 - $119,557	-950 Reduced 8.72%	9,950 $1.22 Million
Q2 2018 Jul 19, 2018	BUY	$75.3 - $105.99 $820,770 - $1.16 Million	10,900 New	10,900 $1.07 Million

624

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.